Prostate Cancer Trial, Recruiting NCT07436078 Sponsor: Barbara Ann Karmanos Cancer Institute Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT07436078
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are already enrolled in a research study called the Detroit Research on Cancer Survivors (Detroit ROCS)

  • People who were diagnosed with breast cancer, prostate cancer, or colorectal cancer on or after January 1, 2013

  • People who have received or are currently receiving cancer care at Karmanos Cancer Institute

  • People who meet at least one of the following guidelines related to cancer genetic testing:

    For breast cancer:

    • Diagnosed with breast cancer at age 50 or younger
    • Diagnosed with a type called "triple-negative" breast cancer
    • Has at least one close family member (parent, sibling, child, grandparent, aunt, or uncle) diagnosed with breast cancer before age 50
    • Has at least one close family member diagnosed with ovarian cancer
    • Has two or more close family members diagnosed with breast or prostate cancer
    • Diagnosed with breast cancer before age 50 and has had a second separate breast cancer at any age
    • Has had two or more separate breast cancer diagnoses at any age

    For prostate cancer:

    • Personal history of high-risk or very high-risk prostate cancer
    • Personal history of prostate cancer that has spread to nearby areas or other parts of the body
    • Personal history of lower-risk prostate cancer along with a family history that includes a father, brother, or multiple relatives with prostate cancer diagnosed before age 60; or at least one relative with breast, ovarian, or pancreatic cancer; or at least one relative with colorectal, ovarian, pancreatic, or kidney cancer

    For colorectal cancer:

    • Diagnosed with colorectal cancer at age 50 or younger
    • Has at least one close family member diagnosed with a hereditary colorectal cancer syndrome (called HNPCC) before age 50
    • Has at least two close family members diagnosed with an HNPCC-related cancer at any age
    • Has had colorectal cancer plus at least one other cancer including endometrial, ovarian, gastric, pancreatic, or prostate cancer

Who may not be able to join:

  • People who have previously had genetic counselling or genetic testing

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Felicity WK Harper, Ph.D, Barbara Ann Karmanos Cancer Institute

Phone: 313-576-9735

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Barbara Ann Karmanos Cancer Institute
Registry
ClinicalTrials.gov
Start date
18 April 2026
Est. completion
1 July 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Uptake of genetic counseling and genetic testing

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov